Issues / Issue · Oct 22 – Nov 20, 2026

Prescription Drug Pricing

12Members · 8 D · 4 R
17Actions · 11 D · 6 R
12States & territories · NH · IA · IL · CO lead
3Bills named

How the conversation moved

Democrat Republican · one dot = one action
Action typeWk ofOct 222Wk ofOct 292Wk ofNov 52Wk ofNov 129Wk ofNov 192Total
Sent lettersTo agencies, companies, officials 3
HearingsHeld, testified or questioned 5
CriticizedA policy, decision or person 1
PraisedCredit for a decision or person 1
Filed or pushed billsNew, reintroduced or passed 5
Other 2

Emerging events

1 thread · 2 of 17 actions

INSULIN Act

1 member

  1. Nov 17Shaheen highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.
  2. Nov 17Shaheen pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.

2 actions →

What each party did · Democrats 11 · Republicans 6

  • 2Sent letters1
  • 2Hearings3
  • 1Criticized0
  • 0Praised1
  • 4Filed or pushed bills1
  • 2Other0

By state

Actions by members from each state, split by party. A joint release counts once for each member on it.

  • NH3
  • IA3
  • IL2
  • CO1
  • VT1
  • WA1
  • AL1
  • MD1

+4 more with fewer actions

Recognitions and tributes not counted.

Every action

17 actions · 17 releases
  1. Nov 20, 2026
    • Bill

      DBennet CO

      Introduced bill to lower prescription drug costs by expanding access to biosimilars.

      Release ↗

  2. Nov 19, 2026
    • Letter

      DShaheen NH $200M

      Led 243 lawmakers urging reauthorization of Special Diabetes Program before December 31 expiration.

      Release ↗

  3. Nov 17, 2026
    • Statement

      DShaheen NH

      Pushed for bipartisan INSULIN Act passage to cap monthly insulin costs at $35.

      ↳ INSULIN Act · Release ↗

    • Statement

      DShaheen NH

      Highlighted health advocacy support for bipartisan INSULIN Act to cap insulin costs at $35 monthly.

      ↳ INSULIN Act · Release ↗

    • Bill

      DWelch VT

      Pushed bipartisan bill to lower prescription drug costs by streamlining patent litigation for generic drugs.

      Release ↗

    • Criticism

      DMurray WA

      Opposed FDA nominee Heidi Overton's confirmation, citing anti-abortion extremism and medication abortion stance.

      Release ↗

    • Hearing

      RGrassley IA

      Held hearing examining competition and transparency to lower prescription drug costs.

      Release ↗

    • Hearing

      DDurbin IL

      Called for passage of bipartisan Drug-price Transparency for Consumers Act during Senate Judiciary Committee hearing.

      Release ↗

    • Hearing

      DDurbin IL

      Questioned witnesses about Medicare's authority to negotiate prescription drug costs during Senate Judiciary Committee hearing.

      Release ↗

    • Hearing

      RGrassley IA

      Chaired hearing on prescription drug costs and bipartisan bills to lower prices.

      Release ↗

    • Hearing

      RBritt AL

      Questioned witnesses at Senate Judiciary Committee hearing on lowering prescription drug costs.

      Release ↗

  4. Nov 11, 2026
    • Letter

      DAlsobrooks MD

      Warned against prediction markets allowing betting on clinical trials and drug approvals.

      Release ↗

    • Bill

      RBergman MI

      Introduced bipartisan bill to preserve prescription drug discounts for safety-net providers.

      Release ↗

  5. Nov 3, 2026
  6. Oct 29, 2026
    • Bill

      DMatsui CA

      Introduced bipartisan bill to protect patient access to affordable medications through 340B program.

      Release ↗

  7. Oct 27, 2026
  8. Oct 22, 2026
    • Letter

      RGrassley IA

      Urged FTC to complete pharmacy benefit manager investigation and release final recommendations.

      Release ↗

Summaries, action types, amounts and positions are read from each press release by AI and can be wrong. Joint releases (same day, same action, matching title or amount) count once. How it works